Hepatitis C Virus Therapy
Reports from University of Paris highlight recent research in hepatitis C virus therapy
Published in Biotech Business Week, May 28th, 2007
Researchers detail in "High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy," new data in hepatitis C virus. In this recent study, researchers in Clichy, France conducted a study "To evaluate the efficacy of peginterferon alfa-2b and ribavirin in unselected consecutive patients with chronic hepatitis C, treated outside of trials, who were relapsers or non-responders to interferon and ribavirin combination. One hundred and fifty-four patients were evaluated."
"There were 101 non-responders and 53 relapsers to standard combination therapy. Patients were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Arthritis
Counseling, Coping Skills Could Reduce Arthritis Disability - Asthma
Ulcerative colitis sufferers find UC quite disruptive to many aspects of daily life - Autoimmune Disease
Natural immune-control system may aid treatment of autoimmune disease and tissue rejection - Breast Cancer
Chemotherapy More Effective When Given Before Breast Cancer Surgery - Breast Cancer
Soy estrogens and breast cancer research reported - Cancer
Scientists Activate New Cancer Drug Using Light and Oxygen - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
